What we do

We believe that closing the gaps between academic cancer research and the pharma industry is crucial. That is why we develop academic cancer projects to clinical proof of concept and enable pharma partners to complete the final steps.

What we do

We believe that closing the gaps between academic cancer research and the pharma industry is crucial. That is why we develop academic cancer projects to clinical proof of concept and enable pharma partners to complete the final steps.

who we are

We are a German biotech company with a dis­­­­tinctive strategy to fight cancer. Our clout relies on each of our individuals' and partners' experience that is combined in teamwork.

who we are

We are a German biotech company with a dis­­­­tinctive strategy to fight cancer. Our clout relies on each of our individuals' and partners' experience that is combined in teamwork.

What's new?

Just like the biotech scene, we are dynamic and constantly evolving. Take part in our journey and follow our latest news:

June 26, 2023

New Website launched

May 28, 2023

Prof. Dr. zur Hausen passed away